Health
Novel protection pathway makes cells resistant to viral infection – Drug Target Review
Researchers reveal that activating the MHC class II transactivator (CIITA) and CD74 genes protected cells against infection by Ebola and SARS-CoV-2.
Posted: 28 August 2020 | Hannah Balfour (Drug Target Review) | No comments yet
Researchers reveal that activating the MHC class II transactivator (CIITA) and CD74 genes protected cells against infection by Ebola and SARS-CoV-2.
Researchers have discovered a new cellular protection mechanism which they demonstrated can prevent viruses, including Ebola and coronaviruses like SARS-CoV-2, from infecting cells. According to the collaborators, the new understanding surrounding cellular mechanisms in…
-
General24 hours agoHow the dismissal of Gough Whitlam’s Labor government in 1975 was sealed by the Senate
-
Noosa News16 hours agoPhotographer Nadia Shevtsova remembered by family in touching tribute after deadly crash at Gold Coast
-
Noosa News18 hours agoWoman’s lucky escape after car rolls and crashes onto tracks before being hit by oncoming train in Kingston, Logan
-
General11 hours agoMajority of Australia’s first Ashes Test squad to feature in Sheffield Shield round four